Andreas Charidimou1. Show Affiliations » 1. From the Hemorrhagic Stroke Research Group, Massachusetts General Hospital, and Harvard Medical School, Massachusetts General Hospital, Boston. andreas.charidimou.09@ucl.ac.uk.
Abstract
Entities: Disease
Mesh： See more » Age FactorsClinical Trials as TopicHumansIntracranial Embolism/therapyPeripheral Vascular Diseases/therapyRiskStroke/therapy
Year: 2017 PMID： 28687717 DOI： 10.1212/WNL.0000000000004220
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910